Inhibitory Antibodies
-
F1941 Anti-CD69 Antibody (Genefrontier patent anti-CD69)Summary: Anti-CD69 Antibody (Genefrontier patent anti-CD69) -
F1942 Anti-CD7 Antibody (Persongen patent anti-CD7)Summary: Anti-CD7 Antibody (Persongen patent anti-CD7) -
F1943 Anti-CDCP1/CD318 Antibody (U.California patent anti-CDCP1)Summary: Anti-CDCP1/CD318 Antibody (U.California patent anti-CDCP1) -
F1944 Anti-CEACAM1/CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1)Summary: Anti-CEACAM1/CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1) -
F1945 Anti-CEACAM5/CEA/CD66e Antibody (Immunomedics patent anti-CEACAM5 (Class III))Summary: Anti-CEACAM5/CEA/CD66e Antibody (Immunomedics patent anti-CEACAM5 (Class III)) -
F1946 Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab-MMAE)Summary: Anti-CEACAM5/CEA/CD66e Antibody (Tusamitamab-MMAE) -
F1947 Anti-CHI3L1 Antibody (Brown U. patent anti-CHI3L1)Summary: Anti-CHI3L1 Antibody (Brown U. patent anti-CHI3L1) -
F1948 Anti-CLDN6 Antibody (IM-302)Summary: Anti-CLDN6 Antibody (IM-302) -
F1949 Anti-CLEC14A Antibody (Scripps Korea patent anti-CLEC14A)Summary: Anti-CLEC14A Antibody (Scripps Korea patent anti-CLEC14A) -
F1950 Anti-CLEC4C Antibody (LFB patent anti-BDCA-2)Summary: Anti-CLEC4C Antibody (LFB patent anti-BDCA-2)

